L03AB11 • peginterferon alfa-2A • Antineoplastic and immunomodulating agents | Immunostimulants | Interferons
Peginterferon alfa-2a is an immunomodulatory agent used in the treatment of chronic hepatitis B and C. It works by stimulating the body's immune response to fight viral infections.
The medication is administered subcutaneously, as directed by a doctor, usually once a week. It is important for patients to follow the treatment regimen and undergo regular tests to monitor the response to therapy.
Patients should be aware of potential side effects, such as fatigue, fever, or flu-like symptoms. It is important to inform the doctor of any unusual symptoms.
Common side effects include fatigue, fever, and flu-like symptoms. In rare cases, severe reactions such as depression or hematologic disorders may occur. Patients should be informed of these risks before use.
Substance: peginterferon alfa-2A
Date of last drug list: 01-04-2014
Commercial code: W52673003
Concentration: 135mcg / 0.5ml
Pharmaceutical form: injection solution in pre-filled syringe
Quantity: 1
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).